Orasure up premarket on yet another Ebola play

• Small cap Orasure (NASDAQ:OSUR) is up 13% premarket on average volume in response to a report that FDA Commissioner Dr. Margaret Hamburg visited the company to discuss developing an Ebola screening product based on its home HIV test.